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History of Natural Killer (NK) cells is 
inextricably woven into the fabric of modern 
immunology: cells have it!
Innate and adaptive immunity: is innate immunity the 
hero?
The purpose of this commentary is to extend the ideas pre-
sented in the article by Takeda and Okumura (1) on Comple-
mentary and Alternative Medicine (CAM) and Natural Killer
(NK) cells. Instances of unintentional omissions due to space
and time constraints or possibilities of tracing evolutionary
origins or using alternative models will be presented briefly. A
second overarching concern is to bring the idea of NK cells
into the broadest realm of biology, rendering NK cells, like all
other living phenomena, accessible in the conceptual, organ-
ismic and universal sense. To arrive at this point historically
would have been somewhat slower without the ferment that
occurred in the world of immunology during the 1800s. As
other aspects of history and culture reveal ideas, creations,
writings  and  material  concepts  were  quite  different  then
from our current understanding. In addition, the interplay of
events  and  various  other  forces,  contrived  or  accidental,
may have contributed to the formation of certain ideas or
concepts or destroyed existing ones. With respect to immu-
nity, there has always been the dominant anthropocentric
theme starting most vividly at the end of the 18th century
with Jenner’s attempts at vaccination (2). No one really
investigated the universality of mechanisms or the possible
existence or at least importance of beings other than humans,
not at least with respect to immunology. However, the current
status of immunity can be described using two general terms:
cellular immunity and humoral immunity. These two great
camps are in turn subdivided into innate immunity and adap-
tive immunity. Innate immunity is characteristically non-
specific, natural non-anticipatory, non-clonal and germline.
On the other hand, adaptive immunity is specific, induced
anticipatory, clonal and somatic. Each of these terms defines
particular attributes and when compared represents distinct
underlying mechanisms. Invertebrates are considered to
possess cells and molecules that almost exclusively effect only
innate responses. Vertebrates retained this innate response
but also evolved the adaptive response.
Was the evolution of the vertebrate immune system 
necessary?
From a more personal observation, it is not clear what caused
the evolution of the adaptive system as a survival strategy
because the long-lived invertebrates—no doubt, extant rela-
tives of extinct species—with a strong innate system have
successfully survived millions of years without the overly
bureaucratic adaptive systems of vertebrates, especially
mammals. Additionally, vulnerability to cancer, once thought
to be a syndrome of vertebrates, probably has relevant
precursors in certain invertebrates. (3–5). Caution should be
exerted when trying to adhere to these rigid characteristics
since there is evidence of sharing of components such as
signal and mediator molecules. A biologically unifying view
might predict this a priori because of the ubiquity of DNA
and the shared homologies of certain molecules such as
hemoglobin (e.g. earthworms and humans). Therefore, why
should the cells, tissues, organs and molecules that they
synthesize and secrete not bear striking resemblances when
the immune system is the discipline being scrutinized?
The development of modern immunology may owe itself 
to invertebrates
These two great divisions of the immune system (innate and
adaptive) that were pioneered by prescience and perhaps the
coalescence of anthropocentric ideas on immunity with the
genius of a zoologist, resulted from a fortuitous experiment
considered as a great experiment in biology (2). This was
first recognized when Metchnikoff successfully demonstrated
phagocytosis in the 19th century, a discovery worthy of the
Nobel Prize in Physiology and Medicine. This discovery of
invertebrate phagocytosis dramatically changed the mono-
lithic world of immunology. His careful and detailed observa-
tions of white cell motility toward and engulfment of foreign30 Commentary
bodies in transparent larvae of starfish and in the water flea,
Daphnia, provoked a major re-evaluation of the nature of
immune systems, admittedly restricted to the human good.
Before his prescient observations, immune systems were
believed to be wholly humoral and there was little emphasis
on the role of leukocytes or white cells. Metchnikoff’s discov-
ery, however, added cellular immunity to the known armory
of humoral immunodefense mechanisms. Serendipity surely
intervened and there was probably the impulse to shout
Archimedes’  eureka when the interpretation of why cells
were moving toward a foreign body was easily visualized.
Thus, the foundation for invoking the concept of self non-
self recognition was laid.
Roughly a century later, this cellular component, and the
animal models from which it was derived are once again at
the center of immunology. Moreover, there is a much greater
willingness to accept that invertebrate model systems have
much more to contribute than was thought, even in the early
1960s when modern immunology was beginning to develop
(6,7). Metchnikoff would have relished this turn of events
because of which immunology is infinitely richer and even
biology in general has reaped substantial benefits, including
the harnessing of invertebrate molecules as complementary
and alternative approaches to biomedicine (8,9). Of course,
we cannot forget the influence of Darwin that surely left its
mark on the 19th century and beyond. In fact, broadly inter-
preted, Darwin led us into the field and Metchnikoff into the
laboratory at least with respect to comparative immunology
(10,11). Evolutionary immunology reaped the benefits of
Metchnikoff and modern immunology advanced concep-
tually when the clonal selection theory of Burnet was
advanced—in essence a Darwinian corollary (12,13). Then
came the network theory and the opening up of immunolo-
gists to the pervasive extension of the immune system
throughout the organism. Additional components and func-
tions existed. Indeed the immune system was broader than
plaque forming cells in the spleen, one of the first assay sys-
tems that led us to further breakthroughs in immunology.
Organismic approaches are inclusive
This organismic approach involving the cells, tissues, organs
and the molecules that they synthesize and secrete has fos-
tered and indeed uncovered an incredible systemic amalgam,
discovering almost daily an infinite array of new connections
and interconnections, revealing ever more minute complexi-
ties almost to the point of incomprehension—as vast as the
universe! We know that the maintenance of a balanced milieu
as first advanced by Claude Bernard is now known to be due
to a finely tuned network whose circuitry is hard wired within
the three great regulatory systems—immune, nervous and
endocrine—accompanied by a measure of flexibility to allow
for changes provoked within and between these systems and
those that might be initiated in the internal and external envi-
ronments. Viewed separately, the immune system has been
assumed to have evolved according to the theory of immuno-
logic surveillance, to ensure the capacity to recognize self
from non-self, a concept adhered to by most immunologists.
In essence, this view assumes that the immune system evolved
to evict internal threats such as cancer. It is canonical—
except for the controversial view, the danger hypothesis that
assumes that immune responses are set into motion as a
result of perceiving danger. The danger hypothesis offers an
alternative to the self non-self mechanism associated with
surveillance (14).
Tumor immunosurveillance by NK cells in 
animal models and humans
Early views on immunologic surveillance
According to Burnet (15), ‘the concept of immunological sur-
veillance is something which has evolved rather inconspicu-
ously in the last ten years. In my mind, it takes the form of a
broad hypothesis, which may soon have the status of a valid
generalization that an important and possibly primary func-
tion of immunological mechanisms is to eliminate cells which
as a result of somatic mutation or some other inheritable
change represent potential danger to life. The only fully rec-
ognized example of such danger is the initiation of malignant
disease—cancer. From human and medical view points, the
essence of the hypothesis is that, without immunological
surveillance, cancer would be more frequent and occur at
younger ages than it presently does. There may also be other
lethal conditions related less directly to weakness of the sur-
veillance function, and the theme must be highly relevant to
any discussion of the ageing process that ascribes importance
to somatic mutation as a factor in senescence. An optimist
might hint that a full understanding of the surveillance func-
tion might lead in one way or another to a reduction in the
incidence of malignant disease and significant prolongation
of life span. As yet, there is no real justification for such
dreams. [His book was] being written not as a part of the
search for an elixir of youth or the cure for cancer but out of
the fascination for the theme by a speculative biologist. For
at least ten years, my chief intellectual interest has been
in immunological and pathological aspects of the interplay
between somatic cells within the mammalian body. Over that
period there has gradually emerged a conviction that such
interactions can be usefully considered from a Darwinian
viewpoint. The mobile cells of the body, including red cells,
granulocytes and lymphocytes, are constantly being produced
and destroyed in large numbers. At least in relation to
lymphocytes it is known that there are wide functional
differences within the population and, in all somatic cells,
mutation and probably other inheritable changes in the
genome can occur. Under such circumstances, it is inevitable
that something equivalent to Darwinian selection and evolu-
tion is going on within those populations (15).’ Since this
period 30 years ago, there has been an infinitesimal growth in
immunology, the most important of which is the elucidation
of the cells involved in cancer cell destruction at least in vitro.eCAM 2004;1(1) 31
Current views on cellular mediators against tumors
NK cells are lymphocytes that were first identified for their
ability to kill tumor cells without deliberate immunization or
activation. Subsequently, they were also found to be able to
kill cells that are infected with certain viruses and to preferen-
tially attack cells that lack expression of major histocompati-
bility complex (MHC) class I antigens. The recent discovery
of novel NK receptors and their ligands has uncovered the
molecular mechanisms that regulate NK activation and func-
tion. Several activating NK cell receptors and costimulatory
molecules have been identified that permit these cells to rec-
ognize tumors and virus-infected cells. These are modulated
by inhibitory receptors that sense the levels of MHC class I
on prospective target cells to prevent unwanted destruction of
healthy tissues. In vitro and in vivo, their cytotoxic ability can
be enhanced by cytokines such as interleukin (IL)-2, IL-12,
IL-15 and interferon α/β (IFN-α/β). In animal studies, they
have been shown to play a critical role in the control of tumor
growth and metastasis and provide innate immunity against
infection with certain viruses. After activation, NK cells
release cytokines and chemokines that induce inflammatory
responses; modulate monocyte, dendritic cells and granulo-
cyte growth and differentiation; and influence subsequent
adaptive immune responses. The underlying mechanism by
which NK cells discriminate between normal and tumor cells
has provided new insights into tumor immunosurveillance
and has suggested new strategies for the treatment of human
cancer (16).
NK cell receptors for tumor recognition
NK cell receptor NKG2D
NK cells function through a diverse array of cell-surface
natural killer receptors (NCRs). NCRs specific for classical
and non-classical MHC class I proteins, expressed in complex
patterns of inhibitory and activating isoforms on overlap-
ping, but distinct, subsets of NK cells, play an important role
in immunosurveillance against cells that have reduced MHC
class I expression as a result of infection or transformation.
NKG2D is an activating NCR, which was first identified on
NK cells but subsequently found on macrophages and a
variety of T cell types. NKG2D ligands in rodents include
the MHC class I-like proteins RAE-1 and H60 whereas in
humans they include ULBPs and the cell stress-inducible pro-
teins MICA and MICB. Expression of either NKG2D ligand
by target cells triggers NK cell cytotoxicity and IFN-γ
secretion by NK cells as well as nitric oxide release and tumor
necrosis factor α transcription by macrophages. Thus,
through their interaction with NKG2D, H-60 and RAE-1 β
are newly identified potent stimulators of innate immunity
(17). NKG2D-MIC and -RAE-1 recognition events have
been implicated in anti-viral and antitumor immune
responses. Crystallographic analyses of NKG2D-MICA and
-RAE-1 complexes reveal an unusual mode of recognition
that apparently tolerates a surprising degree of ligand plastic-
ity while generating affinities that are among the strongest
TCR- or NCR-ligand affinities described so far (18).
Crystal structure of NKG2D and two adapters
NKG2D, a homodimeric lectin-like receptor, is a unique
stimulatory molecule that is found on NK cells, T cells
and activated macrophages. The natural ligands for murine
NKG2D are distant major histocompatibility complex
homologs, retinoic acid early transcript (RAE-1) and H-60
minor histocompatibility antigen. The crystal structure of the
extracellular region of murine NKG2D reveals close homol-
ogy with other C-type lectin receptors such as CD94, Ly49A,
rat MBP-A and CD69. However, the precise mode of dimeric
assembly, surface topography and electrostatic properties
varies among these natural killer receptors. The NKG2D
structure provides the first structural insight into the role and
ligand specificity of this stimulatory receptor in the innate
and adaptive immune system (19). In vitro studies indicate
that NKG2D provides costimulation through an associated
adapter, DAP10, which recruits phosphatidylinositol-3
kinase. In DAP10-deficient mice, CD8+ T cells lack NKG2D
expression and are incapable of mounting tumor-specific
responses. However, DAP10-deficient NK cells express a
functional NKG2D receptor due to the association of
NKG2D with another adapter molecule, DAP12 (also known
as KARAP), which recruits protein tyrosine kinases. Thus,
NKG2D is a versatile receptor that, depending on the
availability of adapter partners, mediates costimulation in
T cells and/or activation in NK cells (20).
NKG2D ligand receptor activates NK cells and 
macrophages inducing tumor immunity
NK cells employ various modes of immune recognition,
‘induced self recognition’ exemplified by the NKG2D recep-
tor-ligand system. The NKG2D immunoreceptor, expressed
by NK cells, and by activated CD8+ T cells and macro-
phages, recognizes one of several cell surface ligands that are
distantly related to MHC class I molecules (i.e. H60 and
RAE1 proteins in mice, and MHC class I chain-related pro-
teins and UL-16-binding proteins in humans). These ligands
are not expressed abundantly by most normal cells but are
upregulated on cells exposed to various forms of cellular
insults. Transcripts of this ligand are found in many different
tissues and in various tumor cells. Cross-linking of NKG2D
with the novel ligand potently activates NK cells and macro-
phages. Tumor cells ectopically expressing the molecule are
efficiently rejected by naive mice and induced strong protec-




According to Medzhitov and Janeway (22), the survival of
multicellular organisms is dependent on their ability to recog-
nize invading microbial pathogens and to induce a variety of
defense reactions. Recent evidence suggests that an evolu-
tionally ancient family of Toll-like receptors plays a crucial
role in the detection of microbial infection and the induction
of immune and inflammatory responses. According to
Beutler et al. (23), in humans, innate immune sensing usually
proceeds through the activation of 10 Toll-like receptors
(TLRs), which in turn leads to the production of cytokine
mediators that create the inflammatory milieu and abet the
development of an adaptive immune response. Each TLR
senses a different molecular component of microbes that
have invaded the host. TLR4 senses bacterial endotoxins (lipo-
polysaccharide), TLR9 senses unmethylated DNA, and TLR3
senses double-stranded RNA. Each receptor has a conserved
signaling element called the TIR (Toll/IL-1 receptor/resist-
ance) motif that transduces a signal through five cytoplasmic
adapter proteins, each of which has a homologous motif.
The integration of signals that the receptors emit is a key
mechanism that needs to be resolved with respect to TLRs.
By creating random germline mutations in mice and screen-
ing for individual animals with differences in signaling poten-
tial, the complex biochemical circuitry of the innate immune
response can be unraveled. Till date, more than 35 000 germ-
line mutants have been produced, and approximately 20 000
have been screened to predict innate immunodeficiency states
(23).
Toll in a protostome invertebrate: mosquito
In their study on mosquitoes, Christophides et al. (24) have
identified 242 Anopheles gambiae genes from 18 gene
families implicated in innate immunity and have detected
marked diversification relative to Drosophila melanogaster.
Immune-related gene families involved in recognition, signal
modulation and effector systems show a marked deficit of
orthologs and excessive gene expansions, possibly reflecting
selection pressures from different pathogens encountered in
these insects’ very different lifestyles. In contrast, the multi-
functional Toll signal transduction pathway is substantially
conserved, presumably because of counter selection for
developmental stability. Representative expression profiles
confirm that sequence diversification is accompanied by
specific responses to different immune challenges. Alternative
RNA splicing may also contribute to the expansion of the
immune repertoire.
Vertebrate ancestors: the tunicates typical deuterostomes
According to a multi-authored effort (25), the first chordates
appear in the fossil records at the time of the Cambrian
explosion, nearly 550 million years ago. The modern ascidian
tadpole represents a plausible approximation to these ances-
tral chordates. Therefore, to explain the origins of chordates
and vertebrates, Paramvir et al. (25) generated a draft of
the protein-coding portion of the genome of the common
ascidian,  Ciona intestinalis. The Ciona genome contains
~16 000 protein-coding genes, similar to that of other inver-
tebrates, but only half that found in vertebrates. Vertebrate
gene families are typically found in simplified form in Ciona,
suggesting that ascidians contain the basic ancestral comple-
ment of genes involved in cell signaling and development.
The ascidian genome has also acquired a number of lineage-
specific innovations, including a group of genes engaged in
cellulose metabolism that is related to those in bacteria and
fungi. All metazoa possess a variety of innate mechanisms to
resist infection by pathogens. In contrast, the lymphocyte-
based adaptive immune system seems to have suddenly
emerged in the jawed vertebrate lineage (26,27). It is still not
clear, however, how this highly sophisticated system involving
hundreds of specific genes has evolved. The genome-wide
identification of immunity-related genes in non-vertebrate
chordates is expected to help elucidate the evolution of both
the innate and adaptive immune systems in vertebrates.
For this analysis, systematic search of the C. intestinalis
genome failed to identify any of the pivotal genes implicated
in adaptive immunity, such as immunoglobulin, T cell recep-
tor and major histocompatibility complex (MHC) class I and
II genes, although we cannot exclude the possibility that
Ciona has highly divergent orthologs of one or more of these
genes. A more convincing ‘negative’ result was obtained by
analyzing the genes that encode the 20S proteasome, which
destroys misfolded proteins (28). Eukaryotic 20S protea-
somes are composed of 14 different gene products; three
possess catalytic activity. Mammals contain a second copy of
each of the genes that encode these three catalytic subunits.
These duplicated genes encode components of an immuno-
proteasome that is essential for the presentation of antigen to
T cells. The Ciona genome contains orthologs for each of the
14 vertebrate proteasome genes, but none for the immuno-
proteasome-specific genes. These observations strongly sug-
gest that Ciona lacks the antigen-presenting system for T
cells. Putative Ciona homologs of the vertebrate MHC-
encoded genes neither exhibit an extensive linkage among
them, nor syntenic conservation with the vertebrate MHC.
Although there is no evidence of adaptive immunity, a
search of the Ciona genome reveals a variety of genes that
are likely to mediate innate immunity. There are a large
number of possible complement genes, including C1q-like
and C6-like genes, three Toll-like receptor genes and a vari-
ety of lectin genes. No interleukin or interleukin-receptor
genes were identified except for an IL-1 receptor and an
IL-17 receptor gene. It is possible that Ciona has evolved
distinctive innate-immunity genes, because a search for the
protein domains found in vertebrate innate-immunity genes
identified a number of Ciona genes that contain these
domains in previously unknown combinations. Despite this
somewhat negative information, there is evidence of lyticeCAM 2004;1(1) 33
activity in numerous invertebrates that destroy experimental
targets (11).
One year later, Azumi et al. (29) proposed that the
mammalian genome encodes several TLRs, with each TLR
responsible for detecting corresponding pathogen-associated
molecular patterns (20). The Ciona genome has only three
TLR genes, characterized by the extracellular leucine-rich
repeat (LRR) motif and the intracellular Toll/IL-1R (TIR)
domain. The genes involved in the TLR signaling pathway
have been identified, including MyD88, characterized by the
TIR and Death domains, IRAK (IL-1 receptor-associated
kinase), TRAF (TNF receptor-associated factor), NFκB and
IκB. Mouse RP105 protein is an atypical member of the
mammalian TLR family as it possesses only multiple LRR
motifs and no TIR domain. Ten gene models with domain
architecture similar to that of RP105 have been identified.
As LRR is a motif that also functions in protein–protein
interactions and is involved in cell–cell communication, it is
conceivable that some of the LRR-containing Ciona genes
actually encode cell-adhesion molecules and not pathogen-
recognizers.
Lectin receptors
According to Vasta et al. (30), ‘The modern era of research
on animal lectins has seen a vast expansion on these founda-
tions. The number of lectins described and the variety of spe-
cies in which these are known has increased rapidly. Sequence
data allows classification into structurally similar groups with
distinct properties, the C-type and S-type (later renamed
galectins) lectins. Functional understanding of lectins from
vertebrates revealed their participation in innate immune
functions, as non-self recognition factors binding to LPS or
bacterial surfaces, opsonizing bacteria and activating com-
plement. The most well characterized molecule, now recog-
nized as a participant in the innate immune system, is the
serum mannose-binding lectin (MBL), a C-type lectin. As a
component of the acute phase response, the lectin-dependent
complement-activation pathway initiated by MBL may con-
stitute the most ancient non-self recognition/defense mecha-
nism. In vertebrates, C-type lectins in another subcategory
known as selectins function to facilitate the adaptive immune
response through lymphocyte, neutrophil and platelet hom-
ing or localization.’
According to King et al. (31), the existence in unicellular
choanoflagellates of proteins used for cell adhesion, i.e.
cadherins, C-type lectins, several tyrosine kinases (TKs) and
tyrosine kinase signaling pathway components and signal
transduction in animals raises the question of their ancestral
function in the progenitor of animals and choanoflagellates.
For example, TKs may act in choanoflagellates to detect
changes in the extracellular environment, as has been demon-
strated through available nutrition. Moreover, animal cell
adhesion proteins, i.e. cadherins, may be derived from ances-
tral proteins that stabilized the interactions between proto-
zoan cells during conjugation or colony formation. C-type
lectins might allow choanoflagellates to distinguish between
and capture different bacterial species by binding specific
sugar groups displayed on bacterial cell walls. This last con-
clusion suggests the early origins of immune systems.
Perspectives on origins of immune system 
components
According to King, et al. (31), a central question in animal
evolution is how multicellular animals evolved from a proto-
zoan ancestor. Of course, we include in this question all the
known functions. One approach to origin of animals is to
determine which developmental proteins predated the origin
of animal and were subsequently co-opted for animal devel-
opment. Comparative genomics can identify the minimal set
of genes in place at the outset of animal evolution by reveal-
ing those shared by all animals and their nearest relatives. To
resolve the mystery of origin, this group has sampled the
diversity of genes expressed by choanoflagellates. These are
unicellular and colonial protozoa closely related to metazoa,
crucial for providing a possible window into early animal evo-
lution. They found that choanoflagellates express representa-
tives of a surprising number of cell signaling and adhesion
protein families that have not previously been isolated from
non-metazoans, including cadherins, C-type lectins, several
tyrosine kinases and tyrosine kinase signaling pathway com-
ponents. Choanoflagellates have a complex and dynamic
tyrosine phosphoprotein profile, and cell proliferation is
selectively affected by tyrosine kinase inhibitors. The expres-
sion in choanoflagellates of proteins involved in cell inter-
action in metazoa demonstrates that these proteins evolved
before the origin of animals and were later co-opted for
development.
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